The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Interferon Regulatory Factor 5 Controls Necrotic Core Formation in Atherosclerotic Lesions by Impairing Efferocytosis
Open accessAbstract
Background: Myeloid cells are central to atherosclerotic lesion development and vulnerable plaque formation. Impaired ability of arterial phagocytes to uptake apoptotic cells (efferocytosis) promotes lesion growth and establishment of a necrotic core. The transcription factor interferon regulatory factor (IRF)-5 is an important modulator of myeloid function and programming. We sought to investigate whether IRF5 affects the formation and phenotype of atherosclerotic lesions. Methods: We investigated the role of IRF5 in atherosclerosis in 2 complementary models. First, atherosclerotic lesion development in hyperlipidemic apolipoprotein E-deficient (ApoE -/- ) mice and ApoE -/- mice with a genetic deletion of IRF5 (ApoE -/- Irf5 -/- ) was compared and then lesion development was assessed in a model of shear stress-modulated vulnerable plaque formation. Results: Both lesion and necrotic core size were significantly reduced in ApoE -/- Irf5 -/- mice compared with IRF5-competent ApoE -/- mice. Necrotic core size was also reduced in the model of shear stress-modulated vulnerable plaque formation. A significant loss of CD11c + macrophages was evident in ApoE -/- Irf5 -/- mice in the aorta, draining lymph nodes, and bone marrow cell cultures, indicating that IRF5 maintains CD11c + macrophages in atherosclerosis. Moreover, we revealed that the CD11c gene is a direct target of IRF5 in macrophages. In the absence of IRF5, CD11c - macrophages displayed a significant increase in expression of the efferocytosis-regulating integrin-β3 and its ligand milk fat globule-epidermal growth factor 8 protein and enhanced efferocytosis in vitro and in situ. Conclusions: IRF5 is detrimental in atherosclerosis by promoting the maintenance of proinflammatory CD11c + macrophages within lesions and controlling the expansion of the necrotic core by impairing efferocytosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The impaired ability of macrophage efferocytosis would enhance atherogenesis [139,140,141] and atherosclerotic plaque instability [142,143,144].”
From Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases (2020) · cites this paper as [142]
In the citing paper
“interferon regulatory factor 5 (IRF5) transcription factor enhances vulnerable plaque formation in hyperlipidemic apolipoprotein E-deficient (ApoE−/−) mice through the induction of pro-inflammatory CD11c+ macrophages within atherosclerotic lesions and increasing the expansion of the necrotic core by inhibiting macrophage efferocytosis [142].”
From Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases (2020) · cites this paper as [142]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
Self-citationObesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
From Vulnerable Plaque to Vulnerable Patient
Naghavi, M., Libby, P., Falk, E., Casscells, S. W., Litovsky, S. H., Rumberger, J. A., Badimón, J. J., Stefanadis, C., Moreno, P., Pasterkamp, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000087481.55887.c9 · Cited by 2,679
Macrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
Transcriptional regulation of macrophage polarization: enabling diversity with identity
Lawrence, T., & Natoli, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3088 · Cited by 2,284
The Immunological Genome Project: networks of gene expression in immune cells
The Immunological Genome Project Consortium, Heng, T. S. P., Painter, M. W., Elpek, K., Lukacs-Kornek, V., Mauermann, N., Turley, S. J., Koller, D., Kim, F. S., Wagers, A. J., et al. (2008) · Nature Immunology · doi:10.1038/ni1008-1091 · Cited by 1,864
Gu, L., Okada, Y., Clinton, S. K., Gerard, C. J., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,574
Identification of a factor that links apoptotic cells to phagocytes
Hanayama, R., Tanaka, M., Miwa, K., Shinohara, A., Iwamatsu, A., & Nagata, S. (2002) · Nature · doi:10.1038/417182a · Cited by 1,401
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses
Krausgruber, T., Blazek, K. D., Smallie, T., Alzabin, S., Lockstone, H. E., Sahgal, N., Hussell, T., Feldmann, M., & Udalova, I. A. (2011) · Nature Immunology · doi:10.1038/ni.1990 · Cited by 1,342
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Macrophages as a therapeutic target to promote diabetic wound healing
Sharifiaghdam, M., Shaabani, E., Majidi, R. F., Smedt, S. C. D., Braeckmans, K., & Fraire, J. C. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.07.016 · Cited by 606
Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?
Engelen, S. E., Robinson, A., Zurke, Y.-X., & Monaco, C. G. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00668-4 · Cited by 455
Self-citationYe, Z.-M., Yang, S., Xia, Y., Hu, R., Chen, S., Li, B., Chen, S.-L., Luo, X., Mao, L., Li, Y., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1409-4 · Cited by 209
Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases
Song, P., An, J., & Zou, M.-H. (2020) · Cells · doi:10.3390/cells9030671 · Cited by 198
“For example, interferon regulatory factor 5 (IRF5) transcription factor enhances vulnerable plaque formation in hyperlipidemic apolipoprotein E-deficient (ApoE-/-) mice through the induction of pro-inflammatory CD11c+ macrophages within atherosclerotic lesions and increasing the expansion of the necrotic core by inhib…”
BackgroundThe Multiple Roles of Interferon Regulatory Factor family in Health and Disease
Wang, L., Zhu, Y., Zhang, N., Xian, Y., Tang, Y., Ye, J., Reza, F., He, G., Wen, X., & Jiang, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01980-4 · Cited by 178
Cole, J. E., Park, I., Ahern, D., Kassiteridi, C., Danso‐Abeam, D., Goddard, M. E., Green, P. A., Maffia, P., & Monaco, C. G. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy109 · Cited by 177
Self-citationMa, C., Xia, R., Yang, S., Liu, L., Zhang, J., Feng, K., Shang, Y., Qu, J., Li, L., Chen, N., et al. (2019) · Theranostics · doi:10.7150/thno.38115 · Cited by 147
Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms
Tajbakhsh, A., Rezaee, M., Kovanen, P. T., & Sahebkar, A. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.02.003 · Cited by 134
Zhang, W., Zhao, J., Wang, R., Jiang, M., Ye, Q., Smith, A. D., Chen, J., & Shi, Y. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13256 · Cited by 132
Advances and challenges in targeting IRF5, a key regulator of inflammation
Almuttaqi, H., & Udalova, I. A. (2018) · FEBS Journal · doi:10.1111/febs.14654 · Cited by 116
Self-citationSun, J., Singh, P., Shami, A., Kluza, E., Pan, M., Djordjevic, D., Michaelsen, N. B., Kennbäck, C., van der Wel, N. N., Orho‐Melander, M., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.008 · Cited by 114
Self-citationSystematic integrated analysis of genetic and epigenetic variation in diabetic kidney disease
Sheng, X., Qiu, C., Liu, H., Gluck, C. A., Hsu, J. Y., He, J., Hsu, C., Sha, D., Weir, M. R., Isakova, T., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005905117 · Cited by 106
Liu, T., Xiang, A., Peng, T., Doran, A. C., Tracey, K. J., Barnes, B. J., Tabas, I. A., Son, M., & Diamond, B. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907490116 · Cited by 93
Edsfeldt, A., Swart, M., Singh, P., Dib, L. H., Sun, J., Cole, J. E., Park, I., Al-Sharify, D., Persson, A. F., Nitulescu, M., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab920 · Cited by 91
Self-citationCorbin, A., Gomez-Vazquez, M., Khoyratty, T. E., Berthold, D. L., Almuttaqi, H., Attar, M., Arnold, I. C., Powrie, F. M., Sansom, S. N., & Udalova, I. A. (2020) · Science Immunology · doi:10.1126/sciimmunol.aax6085 · Cited by 87
Self-citationWang, Y., Liu, X.-Y., Wang, Y., Zhao, W.-X., Li, F.-D., Guo, P.-R., Fan, Q., & Wu, X.-F. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102763 · Cited by 85
Targeting senescent cells to attenuate cardiovascular disease progression
Song, P., Zhao, Q., & Zou, M. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101072 · Cited by 81
Yang, S., Xia, Y., Luo, X., Chen, S., Li, B., Ye, Z.-M., Chen, S., Mao, L., Jin, H., Li, Y., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.07.011 · Cited by 77
Signals governing monocyte differentiation during inflammation
Orozco, S. L., Canny, S., & Hamerman, J. A. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.07.007 · Cited by 69
Senatus, L. M., López‐Díez, R., Egaña-Gorroño, L., Liu, J., Hu, J., Daffu, G. K., Li, Q., Rahman, K., Vengrenyuk, Y., Barrett, T. J., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137289 · Cited by 70
Potential Mechanisms and Effects of Efferocytosis in Atherosclerosis
Wang, L., Li, H., Tang, Y., & Yao, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.585285 · Cited by 67
Park, I., Goddard, M. E., Cole, J. E., Zanin, N., Lyytikäinen, L., Lehtimäki, T. J., Andreakos, E., Feldmann, M., Udalova, I. A., Drozdov, I. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27862-9 · Cited by 61
Self-citationTherapeutic Targeting of IRFs: Pathway-Dependence or Structure-Based?
Thompson, C. D., Matta, B., & Barnes, B. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02622 · Cited by 57
Li, Y., Sang, Y., Chang, Y., Xu, C., Lin, Y., Zhang, Y., Chiu, P. C. N., Yeung, W. S. B., Zhou, H., Dong, N., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.064391 · Cited by 61
Wei, J., Tang, D., Lu, C., Yang, J., Lu, Y., Wang, Y., Jia, L., Wang, J., Ru, W., Lü, Y., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0169-x · Cited by 54
Kowara, M., & Cudnoch‐Jędrzejewska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073513 · Cited by 54
Metabolic and Molecular Mechanisms of Macrophage Polarisation and Adipose Tissue Insulin Resistance
Orliaguet, L., Ejlalmanesh, T., & Alzaïd, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165731 · Cited by 53
Dong, X., Suo, Y., Yu, J. Z., Yu, F., Feng, L., Zheng, J., Li, G., Ma, S., Hao, Y., Zhang, H., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c00216 · Cited by 50
Molecular mechanisms and genetic regulation in atherosclerosis
Jackson, A. O., Regine, M. A., Chakrabarti, S., & Long, S. (2018) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2018.09.006 · Cited by 52
Zhang, J., Zhao, X., Guo, Y., Liu, Z., Wei, S., Yuan, Q., Shang, H., Sang, W., Cui, S., Xu, T., et al. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.317204 · Cited by 50
IRF5-mediated immune responses and its implications in immunological disorders
Kaur, A., Lee, L., Chow, S.-C., & Fang, C.-M. (2018) · International Reviews of Immunology · doi:10.1080/08830185.2018.1469629 · Cited by 44
Ma, C., Zhang, J., Yang, S., Hua, Y., Su, J., Shang, Y., Wang, Z., Feng, K., Zhang, J., Yang, X., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.610550 · Cited by 41
Liu, Y., Huan, W., Wu, J., Zou, S., & Qu, L. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.52993 · Cited by 40
Dhawan, U. K., Singhal, A., & Subramanian, M. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105699 · Cited by 41
CD200 Limits Monopoiesis and Monocyte Recruitment in Atherosclerosis
Kassiteridi, C., Cole, J. E., Griseri, T., Falck-Hansen, M., Goddard, M. E., Seneviratne, A. N., Green, P. A., Park, I., Shami, A., Pattarabanjird, T., et al. (2021) · Circulation Research · doi:10.1161/circresaha.119.316062 · Cited by 37
Self-citationDefactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation
Ryzhakov, G., Almuttaqi, H., Corbin, A., Berthold, D. L., Khoyratty, T. E., Eames, H. L., Bullers, S. J., Pearson, C. F., Ai, Z., Zec, K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27038-5 · Cited by 36
Self-citationDiverse mechanisms of IRF5 action in inflammatory responses
Khoyratty, T. E., & Udalova, I. A. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.03.012 · Cited by 34
Self-citationTang, Y., Xu, Z., Tang, J., Xu, Y., Li, Z., Wang, W., Wu, L., Xi, K., Gu, Y., & Chen, L. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202658 · Cited by 35
Xiao, Q., Che, X., Cai, B., Tao, Z., Zhang, H., Shao, Q., & Pu, J. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14715 · Cited by 33
Zhang, Y., Ding, J., Wang, Y., Feng, X., Du, M., & Liu, P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.731769 · Cited by 33
Sharifiaghdam, M., Shaabani, E., Sharifiaghdam, Z., Keersmaecker, H. D., Lucas, B., Lammens, J., Ghanbari, H., Teimoori‐Toolabi, L., Vervaet, C., Beer, T. D., et al. (2021) · Nanoscale · doi:10.1039/d1nr03830c · Cited by 32
Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe–/– mice
Leipner, J., Dederichs, T.-S., von Ehr, A., Rauterberg, S., Ehlert, C. A., Merz, J., Dufner, B., Hoppe, N., Krebs, K., Heidt, T., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101250 · Cited by 31
Resolvin T4 enhances macrophage cholesterol efflux to reduce vascular disease
Walker, M. E., Matteis, R. D., Perretti, M., & Dalli, J. (2024) · Nature Communications · doi:10.1038/s41467-024-44868-1 · Cited by 30
Ning, K., Wang, M.-J., Ge, L., Zhang, Y., Li, M.-Y., Yang, B., Chen, Y., Huang, Y., Li, Z., Huang, Y., et al. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.264887 · Cited by 29
Xie, X.-D., Dong, S., Liu, R., Shi, L., & Zhu, T. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04060-4 · Cited by 28
Li, X., Chen, Y., Cao, X., Feng, W., Chen, Y., & Zhang, J. (2025) · ACS Nano · doi:10.1021/acsnano.4c16585 · Cited by 28
Jing, J., Zhu, C., Gong, R., Qi, X., Zhang, Y., & Zhang, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114201 · Cited by 27
New Concepts on the Pathophysiology of Acute Coronary Syndrome
Yuan, D., Chu, J., Qian, J., Lin, H., Zhu, G., Chen, F., & Liu, X. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2404112 · Cited by 26
IRF5 siRNA Nanoimmunotherapy: Restoring Macrophage Efferocytosis in Atherosclerosis
He, Z., Luo, Y., Duan, Z., Su, B., Zeng, W., Guo, Y., Li, Y., He, X., Shi, H., Zhou, Z., et al. (2025) · Circulation · doi:10.1161/circulationaha.125.075352 · Cited by 25
Macrophages in Atheromatous Plaque Developmental Stages
von Ehr, A., Bode, C., & Hilgendorf, I. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.865367 · Cited by 24
Ca2+ Flux: Searching for a Role in Efferocytosis of Apoptotic Cells in Atherosclerosis
Tajbakhsh, A., Kovanen, P. T., Rezaee, M., Banach, M., & Sahebkar, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122047 · Cited by 24
Defining the Role of Monocytes in Sjögren’s Syndrome
Sequí-Sabater, J. M., & Beretta, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112765 · Cited by 24
Bai, Q., Lao, X., Pang, S., Zhao, Y., Liu, Y., Tian, X. Y., & Hao, J. (2025) · Advanced Materials · doi:10.1002/adma.202420189 · Cited by 21
Recent advances in dead cell clearance during acute lung injury and repair
Noone, P. M., & Reddy, S. P. (2021) · Faculty Reviews · doi:10.12703/r/10-33 · Cited by 21
Synergistic inflammatory signaling by cGAS may be involved in the development of atherosclerosis
Lu, G., Chen, S.-C., Xia, Y., Ye, Z.-M., Cao, F., & Hu, B. (2021) · Aging · doi:10.18632/aging.202491 · Cited by 20
Che, X., Xiao, Q., Song, W., Zhang, H., Sun, B., Geng, N., Tao, Z., Shao, Q., & Pu, J. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018455 · Cited by 20
Yu, X., Rehman, A. U., Dang, L., Zhang, X., Liu, J., Xiong, X., Chen, G., & Jian, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1535823 · Cited by 19
Yuan, J., Liao, Y.-S., Zhang, T.-C., Tang, Y.-Q., Yu, P., Liu, Y., Cai, D., Yu, S., & Zhao, L. (2024) · Translational Stroke Research · doi:10.1007/s12975-024-01255-8 · Cited by 20
Functional diversity of macrophages in vascular biology and disease
Park, I., Kassiteridi, C., & Monaco, C. G. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.10.005 · Cited by 19
Self-citationXu, Y., Zhang, Y., Xu, Y., Zang, G., Li, B., Xia, H., & Yuan, W. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.106003 · Cited by 19
Air pollution and atherosclerosis
Seneviratne, A. N., & Miller, M. R. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119240 · Cited by 21
Self-citationIRF5 governs macrophage adventitial infiltration to fuel abdominal aortic aneurysm formation
Wang, Y., Liu, Z., Song, S., Wang, J., Jin, C., Jia, L., Ma, Y., Yuan, T., Cai, Z., & Xiang, M. (2024) · JCI Insight · doi:10.1172/jci.insight.171488 · Cited by 18
Li, Z., Zou, X., Lu, R., Wan, X., Sun, S., Wang, S., Qu, Y., Zhang, Y., Li, Z., Yang, L. M., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111452 · Cited by 18
Defective efferocytosis of vascular cells in heart disease
Singh, B., Li, K. S., Cui, K., Peng, Q., Cowan, D. B., Wang, D., Chen, K., & Chen, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1031293 · Cited by 18
Liu, Y., Lu, P., Wang, Y., Morrow, B. E., Zhou, B., & Zheng, D. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012941 · Cited by 16
Insights on TAM Formation from a Boolean Model of Macrophage Polarization Based on In Vitro Studies
Marku, M., Raynal, F., Verstraete, N., Domagała, M., Madrid-Mencía, M., Poupot, M., Fournié, J.-J., Ysebaert, L., & Pancaldi, V. (2020) · Cancers · doi:10.3390/cancers12123664 · Cited by 14
Cao, Y., Yao, J., Gao, W., Cao, Z., Diabakte, K., Wang, L., Sun, X., & Tian, Y. (2022) · International Heart Journal · doi:10.1536/ihj.21-233 · Cited by 15
Yan, S., Meng, L., Guo, X., Chen, Z., Zhang, Y.-M., & Li, Y. (2022) · Journal of International Medical Research · doi:10.1177/03000605211039480 · Cited by 13
Łopacinska, N., Wesoły, J., & Bluyssen, H. A. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010205 · Cited by 14
Wu, Z., Geng, J., Bai, Y., Qi, Y., Chang, C. C., Jiao, Y., & Guo, Z. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112922 · Cited by 12
Xu, Y., Chen, J., Liu, Y., Zhang, G., Miao, G., Wu, J., Lu, K., Zhao, Y., Zhang, W., Zheng, L., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf523 · Cited by 11
Zhang, D., Li, X., Jing, B., Shi, H., Chang, S., Chen, Z., Zheng, Y., Pan, Y., Qian, G., & Zhao, G. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11387 · Cited by 10
Du, Z., Wan, P., Du, M., Li, S., Yan, Q., Sun, S., Tang, C., Jiang, Z., Li, S., Shi, G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66121-z · Cited by 8
More Than a Cleanup Crew: The Expanding Biology of Efferocytosis
Pandit, R., Hillman, H., Williams, J. W., & Yurdagul, A. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.323211 · Cited by 8
Shi, J., Pan, H., Liu, K., Pan, M., & Si, G.-J. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108460 · Cited by 8
Antonczyk, A., Kluzek, K., Herbich, N., Boroujeni, M. E., Krist, B., Wronka, D., Karlik, A., Przybył, Ł., Plewiński, A., Wesoły, J., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1471182 · Cited by 7
Lei, W., Qian, S., Zhu, X., & Hu, J. (2023) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-023-00576-w · Cited by 7
Emerging areas for therapeutic discovery in SLE
Maria, N. I., & Davidson, A. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.09.004 · Cited by 8
Huang, Z., Shen, S., Li, W., Wang, M., Yu, Y., Luo, W., Han, X., Xu, Z., Min, J., Long, X., et al. (2025) · Advanced Science · doi:10.1002/advs.202503192 · Cited by 7
Shao, Q., Wang, H., Li, S., Zeng, M., Zhang, S., & Yan, X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083722 · Cited by 6
Environmental modulators of vascular physiology and inflammation
Seneviratne, A. N., Majumdar, A., Surendranath, K., & Miller, M. R. (2025) · Experimental Physiology · doi:10.1113/ep092309 · Cited by 5
Self-citationHuang, J., Wang, J., Chen, H. H., Guo, F., & Yuan, X. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1795987 · Cited by 5
Liu, Y., He, Y., Cao, J., Lu, H., Zou, R., Zuo, Z., Li, R., Zhang, Y., & Sun, J. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127138 · Cited by 5
IRF-5 Expression in Myeloid Cells Is Required for Splenomegaly in L. donovani Infected Mice
Mai, L. T., Smans, M., Silva‐Barrios, S., Fabié, A., & Stäger, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03071 · Cited by 5
Posadas‐Sánchez, R., Cardoso-Saldaña, G. C., Fragoso, J. M., & Vargas‐Alarcón, G. (2021) · Biomolecules · doi:10.3390/biom11030443 · Cited by 5
The role of interferon regulatory factors in atherosclerosis
Wang, Y., Fang, T., Zheng, X., & Huangfu, N. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1606034 · Cited by 4
The Role of Ubiquitination on Macrophages in Cardiovascular Diseases and Targeted Treatment
Wang, L., Zhang, Y., Yue, J., & Zhou, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094260 · Cited by 4
Pei, Y., Lin, W., Zhang, T., Chu, X., Xu, H., Sun, Y., Xu, M., Xu, Y., Huang, F., Huang, D., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf215 · Cited by 4
The role of integrin-related genes in atherosclerosis complicated by abdominal aortic aneurysm
Hong, D., Ma, L., Jin, L., Tang, L., Chen, L., & Qiu, Z. (2024) · Medicine · doi:10.1097/md.0000000000040293 · Cited by 3
LncRNA SCARNA8 promotes atherosclerotic plaque instability by inhibiting macrophage efferocytosis
Yin, X., Chen, X., Wang, T., Yang, J., Yu, J., & Yang, J. (2025) · Epigenetics · doi:10.1080/15592294.2025.2487317 · Cited by 3
Luo, X., Zhao, C., Yu, F., Dong, X., Hao, Y., Zhang, H., Liu, B., & Jiang, Y. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.176037 · Cited by 2
Disruption of the novel nested gene Aff3ir mediates disturbed flow-induced atherosclerosis in mice
He, S., Huang, L., Chen, Z., Yuan, Z., Zhao, Y., Zeng, L., Zhu, Y., & He, J. (2025) · eLife · doi:10.7554/elife.103413.3 · Cited by 2
Unravelling immune cell complexity in atherosclerosis
Clément, M., & Mallat, Z. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy165 · Cited by 2
Corbin, A., Gomez-Vazquez, M., Khoyratty, T. E., Berthold, D. L., Almuttaqi, H., Attar, M., Arnold, I. C., Powrie, F. M., Sansom, S. N., & Udalova, I. A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/601963 · Cited by 2
Self-citationAdvancing therapeutic targeting of the vulnerable plaque
Newman, A. A. C., Cyr, Y., & Moore, K. J. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac060 · Cited by 2
Gong, Y., Yan, S. R., Fang, N., Zhang, Y., Zhang, N., Li, L., Wang, Z., Wang, K., Hou, T., Ji, X., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4666347/v1 · Cited by 2
Mechanisms of aging in the cardiovascular system: challenges and opportunities
Zhao, X., Yang, X., Lin, Y., Lei, R., Ding, W., He, X.-Y., Cao, Y. J., Zhang, D., Liu, P., Liang, M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1635736 · Cited by 4
PYK2 controls intestinal inflammation via activation of IRF5 in macrophagesPreprint
Ryzhakov, G., Almuttaqi, H., Corbin, A., Khoyratty, T. E., Berthold, D. L., Bullers, S. J., Eames, H. L., Ai, Z., Bonham, S., Fischer, R., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.24.113076 · Cited by 1
Self-citationZou, X., Li, Z., WAN, X., Sun, S., Wang, S., Qu, N., Zhang, Y., Lu, R., Li, Z., Yang, L. M., et al. (2022) · SSRN Electronic Journal · doi:10.22541/au.170669100.03220590/v1 · Cited by 1
Disruption of the novel nested gene Aff3ir mediates disturbed flow-induced atherosclerosis in micePreprint
He, S., Huang, L., Chen, Z., Yuan, Z., Zhao, Y., Zeng, L., Zhu, Y., & He, J. (2024) · eLife · doi:10.7554/elife.103413 · Cited by 1
Metadata
- Authors
- Seneviratne, A. N., Edsfeldt, A., Cole, J. E., Kassiteridi, C., Swart, M., Park, I., Green, P., Khoyratty, T., Saliba, D., Goddard, M. E., Sansom, S. N., Goncalves, I., Krams, R., Udalova, I. A., & Monaco, C.
- Affiliations
- Queen Mary University of London (GB)
- From Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, United Kingdom (A.N.S., A.E., J.E.C., C.K., M.S., I.P., P.G., T.K., D.S., M.E.G., S.N.S., I.A.U., C.M.); Department of Bioengineering, Imperial College London, United Kingdom (A.N.S., R.K.); Experimental Cardiovascular Research Unit, Clinical Research Centre, Clinical Sciences Malmö, Lund University, Sweden (A.E., I.G.); Department of Cardiology, Skåne...
- Corresponding author
- Monaco, Claudia
- ORCID
- Venue
- Circulation
- Published
- 2017-09-19
- Volume
- 136
- Issue
- 12
- Pages
- 1140-1154
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC5598917
- OpenAlex
- W2735394628
- Cited by
- 117
- References
- 40
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 12 · 2023: 8 · 2022: 15 · 2021: 16 · 2020: 14 · 2019: 10 · 2018: 9 · 2017: 1
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Circulation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion, cc-by)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Funders
- Kennedy Trust for Rheumatology Research (KENN161701)
- British Heart Foundation (PG/15/49/31595, RG/11/13/29055)
- Novo Nordisk Fonden (NNF15SA0018346, NNF15SA0018486)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- IRF5, atherosclerosis, necrotic core, efferocytosis, CD11c+ macrophages, CD61, MFG-E8, vulnerable plaque, shear stress, ApoE-deficient mice, transcriptional regulation
- MeSH terms
- Animals, Aorta, Apolipoproteins E, Bone Marrow Cells, Cells, Cultured, Immunohistochemistry, Lymph Nodes, Macrophages, Mice, Inbred C57BL, Necrosis, Phagocytosis, Mice, Knockout, Shear Strength, CD11c Antigen, Integrin beta3, Atherosclerosis, Interferon Regulatory Factors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review